Literature DB >> 27567532

Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.

Tyler J Liban1, Michael J Thwaites2, Frederick A Dick2, Seth M Rubin3.   

Abstract

The human pocket proteins retinoblastoma (Rb), p107, and p130 are critical negative regulators of the cell cycle and contribute to tumor suppression. While strong structural conservation within the pocket protein family provides for some functional redundancy, important differences have been observed and may underlie the reason that Rb is a uniquely potent tumor suppressor. It has been proposed that distinct pocket protein activities are mediated by their different E2F transcription factor binding partners. In humans, Rb binds E2F1-E2F5, whereas p107 and p130 almost exclusively associate with E2F4 and E2F5. To identify the molecular determinants of this specificity, we compared the crystal structures of Rb and p107 pocket domains and identified several key residues that contribute to E2F selectivity in the pocket family. Mutation of these residues in p107 to match the analogous residue in Rb results in an increase in affinity for E2F1 and E2F2 and an increase in the ability of p107 to inhibit E2F2 transactivation. Additionally, we investigated how phosphorylation by Cyclin-dependent kinase on distinct residues regulates p107 affinity for the E2F4 transactivation domain. We found that phosphorylation of residues S650 and S975 weakens the E2F4 transactivation domain binding. Our data reveal molecular features of pocket proteins that are responsible for their similarities and differences in function and regulation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell cycle regulation; isothermal titration calorimetry; protein phosphorylation; protein–protein interactions; transcription factors

Mesh:

Substances:

Year:  2016        PMID: 27567532      PMCID: PMC5048593          DOI: 10.1016/j.jmb.2016.08.017

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  46 in total

1.  Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation.

Authors:  J Garriga; A Limón; X Mayol; S G Rane; J H Albrecht; E P Reddy; V Andrés; X Graña
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

2.  Collective inhibition of pRB family proteins by phosphorylation in cells with p16INK4a loss or cyclin E overexpression.

Authors:  S Ashizawa; H Nishizawa; M Yamada; H Higashi; T Kondo; H Ozawa; A Kakita; M Hatakeyama
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

3.  Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4.

Authors:  Thomas Farkas; Klaus Hansen; Karin Holm; Jiri Lukas; Jiri Bartek
Journal:  J Biol Chem       Date:  2002-05-02       Impact factor: 5.157

4.  Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.

Authors:  Ulrich K Binné; Marie K Classon; Frederick A Dick; Wenyi Wei; Michael Rape; William G Kaelin; Anders M Näär; Nicholas J Dyson
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

5.  B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation.

Authors:  Girish Jayadeva; Alison Kurimchak; Judit Garriga; Elena Sotillo; Anthony J Davis; Dale S Haines; Marc Mumby; Xavier Graña
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

6.  p107 in the public eye: an Rb understudy and more.

Authors:  Stacey E Wirt; Julien Sage
Journal:  Cell Div       Date:  2010-04-02       Impact factor: 5.130

Review 7.  Molecular mechanisms underlying RB protein function.

Authors:  Frederick A Dick; Seth M Rubin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04-18       Impact factor: 94.444

8.  Shared role of the pRB-related p130 and p107 proteins in limb development.

Authors:  D Cobrinik; M H Lee; G Hannon; G Mulligan; R T Bronson; N Dyson; E Harlow; D Beach; R A Weinberg; T Jacks
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

9.  Targeted disruption of p107: functional overlap between p107 and Rb.

Authors:  M H Lee; B O Williams; G Mulligan; S Mukai; R T Bronson; N Dyson; E Harlow; T Jacks
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  14 in total

1.  Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.

Authors:  Tyler J Liban; Edgar M Medina; Sarvind Tripathi; Satyaki Sengupta; R William Henry; Nicolas E Buchler; Seth M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

2.  ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway.

Authors:  Zihui Fang; Yue Wang; Zehua Wang; Meishu Xu; Songrong Ren; Da Yang; Mei Hong; Wen Xie
Journal:  Cancer Res       Date:  2020-08-21       Impact factor: 12.701

3.  Transcriptional E2F1/2/3/6 as potential prognostic biomarkers in cutaneous melanoma.

Authors:  Jing Li; Xiao-Lei Shu; Qing Shao; Qian Luo; Qing-Chun Diao; Xin Zhang; Jiang-Dong Sui; Jing Guo; Dan Tao; Xian Zhou; Ying Wang; Can Wang
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

4.  Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.

Authors:  Satoko Iwahori; Angie C Umaña; Halena R VanDeusen; Robert F Kalejta
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

5.  Structural basis for tunable affinity and specificity of LxCxE-dependent protein interactions with the retinoblastoma protein family.

Authors:  Sivasankar Putta; Lucia Alvarez; Stephan Lüdtke; Peter Sehr; Gerd A Müller; Samantha M Fernandez; Sarvind Tripathi; Joe Lewis; Toby J Gibson; Lucia B Chemes; Seth M Rubin
Journal:  Structure       Date:  2022-06-17       Impact factor: 5.871

6.  DREAM interrupted: severing LIN-35-MuvB association in Caenorhabditis elegans impairs DREAM function but not its chromatin localization.

Authors:  Paul D Goetsch; Susan Strome
Journal:  Genetics       Date:  2022-07-04       Impact factor: 4.402

Review 7.  Structure and function of MuvB complexes.

Authors:  Gerd A Müller; Anushweta Asthana; Seth M Rubin
Journal:  Oncogene       Date:  2022-04-26       Impact factor: 8.756

8.  MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.

Authors:  Xiupeng Xu; Ning Cai; Tongle Zhi; Zhongyuan Bao; Dong Wang; Yinlong Liu; Kuan Jiang; Liang Fan; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 9.  The broken cycle: E2F dysfunction in cancer.

Authors:  Lindsey N Kent; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

10.  The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.

Authors:  Leilei Zhang; Xiaoyu He; Fang Li; Hui Pan; Xiaolin Huang; Xuyang Wen; He Zhang; Bin Li; Shengfang Ge; Xiaofang Xu; Renbing Jia; Xianqun Fan
Journal:  J Exp Clin Cancer Res       Date:  2018-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.